Antares Pharma Inc (NASDAQ:ATRS)

Delayed Data
As of 4:00pm ET
 -0.11 / -4.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +50.86% increase from the last price of 2.32.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.50%
Growthannually 105.45%


Growthquarterly -3.75%
Growthannually 60.31%
Key to the earnings and sales forecast charts.